Skip to content

clinical trial for Comparison of 2 drugs ketamine and 2%lidocaine in patients who are undergoing resection of bladder tumor for reducing the incidence of catheter related bladder discomfort

Comparison of intravenous ketamine and intravenous lidocaine for prevention of postoperative catheter related bladder discomfort in TURBT patients : Randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045172
Enrollment
120
Registered
2022-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: KETAMINE: KETAMINE is a anesthetic agent used for induction of anesthesia. it also has analgesic, local ansethetic and antimuscarinic properties in this study ketamine is given as bolus

Sponsors

national cancer institute AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective TURBT under general anesthesia 2. Age group 18-65 years 3. ASA I-II

Exclusion criteria

Exclusion criteria: 1. Delayed extubation 2. Hypertensive patients 3. Need of admission to the intensive care unit 4. History of chronic pain or opium use or on opioid medications 5. History of urinary obstruction 6. History of neurological disorder 7. Severe liver or heart disease 8. History of overactive bladder (urinating more than 3 times at night or 8 times in 24 hour 9. Morbid obesity

Design outcomes

Primary

MeasureTime frame
Comparison of ketamine and 2% lidoccaine for catheter related bladder discomfort in postoperative patients of transurethral resection of bladder tumorTimepoint: 0, 1, 2,6 and 24 hr

Secondary

MeasureTime frame
pain, sedation level, rescue analgesia used in both the groups. also the side effects observed in both the drug groups will be notedTimepoint: 0,1,2,6,24 hrs

Countries

India

Contacts

Public ContactDr Anuja pandit

DrBRAIRCH AIIMS

anujapandit@yahoo.co.in9710030457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026